We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$3.27B
AUM Growth
-$145M
(-4.2%)
Cap. Flow
-$201M
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
25.06%
Holding
179
New
14
Increased
49
Reduced
71
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$50.3M |
| 2 |
SBNY
Signature Bank
SBNY
|
+$33.8M |
| 3 |
East-West Bancorp
EWBC
|
+$20.9M |
| 4 |
TSMC
TSM
|
+$18.2M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecolab
ECL
|
+$24.6M |
| 2 |
Wells Fargo
WFC
|
+$22.1M |
| 3 |
AGN
Allergan plc
AGN
|
+$22M |
| 4 |
New Oriental
EDU
|
+$21.7M |
| 5 |
W.W. Grainger
GWW
|
+$20.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.06% |
| 2 | Healthcare | 15.47% |
| 3 | Financials | 15.03% |
| 4 | Communication Services | 14.24% |
| 5 | Technology | 13.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
101
DELISTED
WestRock Company
WRK
| $7.62M | 0.23% |
150,000
-20,000
| -12% | -$983K |
|
|
102
Ecolab
ECL
$78.1B
| $7.03M | 0.22% |
60,000
-210,365
| -78% | -$24.6M |
|
103
Bristol-Myers Squibb
BMY
$130B
| $6.75M | 0.21% |
115,560
-25,000
| -18% | -$1.37M |
|
104
Exelixis
EXEL
$12.5B
| $6.71M | 0.21% |
450,000
+85,000
| +23% | +$1.23M |
|
105
Exponent
EXPO
$3.22B
| $6.69M | 0.2% |
222,000
-178,000
| -45% | -$5.16M |
|
106
Wolverine World Wide
WWW
$1.48B
| $6.58M | 0.2% |
300,000
-125,000
| -29% | -$2.83M |
|
|
AGN
107
DELISTED
Allergan plc
AGN
| $6.04M | 0.18% |
28,744
-106,000
| -79% | -$22M |
|
108
Estee Lauder
EL
$31.7B
| $5.74M | 0.18% |
75,000
-10,000
| -12% | -$813K |
|
109
Itaú Unibanco
ITUB
$81.6B
| $4.88M | 0.15% |
979,502
-2
| -0% | -$10 |
|
|
PFPT
110
DELISTED
Proofpoint, Inc.
PFPT
| $4.75M | 0.15% |
67,200
+23,000
| +52% | +$1.73M |
|
111
Fomento Económico Mexicano
FMX
$40B
| $4.71M | 0.14% |
61,820
-27,500
| -31% | -$2.35M |
|
112
Expedia Group
EXPE
$39.1B
| $4.53M | 0.14% |
40,000
-20,000
| -33% | -$2.44M |
|
|
ALXN
113
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.45M | 0.14% |
36,400
-3,000
| -8% | -$367K |
|
|
EA
114
DELISTED
Electronic Arts
EA
| $4.33M | 0.13% |
55,000
-20,000
| -27% | -$1.61M |
|
115
Glaukos
GKOS
$11B
| $4.29M | 0.13% |
125,000
| – | – |
|
|
KYNB
116
Kyntra Bio
KYNB
$28.7M
| $4.26M | 0.13% |
7,960
| – | – |
|
117
TAL Education Group
TAL
$6.58B
| $4.21M | 0.13% |
360,000
+60,000
| +20% | +$733K |
|
|
TSRO
118
DELISTED
TESARO, Inc.
TSRO
| $3.9M | 0.12% |
29,000
+14,000
| +93% | +$1.77M |
|
119
Neurocrine Biosciences
NBIX
$15.9B
| $3.87M | 0.12% |
100,000
| – | – |
|
|
MON
120
DELISTED
Monsanto Co
MON
| $3.68M | 0.11% |
35,000
| – | – |
|
121
Acadia Pharmaceuticals
ACAD
$5.07B
| $3.46M | 0.11% |
+120,000
| New | +$3.17M |
|
|
NBIS
122
Nebius Group N.V.
NBIS
$65.8B
| $3.42M | 0.1% |
170,000
-19,000
| -10% | -$374K |
|
123
Galicia Financial Group
GGAL
$7.1B
| $3.35M | 0.1% |
124,500
| – | – |
|
124
Merck
MRK
$328B
| $3.3M | 0.1% |
58,688
+47,160
| +409% | +$2.76M |
|
|
BETR
125
DELISTED
Amplify Snack Brands, Inc.
BETR
| $3.08M | 0.09% |
350,000
+50,000
| +17% | +$606K |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2016 Portfolio in Review
As of Q4 2016, Handelsbanken Fonder held 179 positions worth $3.27B, down 4.2% from $3.41B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Handelsbanken Fonder withdrew a net $201M in Q4 2016, closing 21 positions and reducing 71 holdings. Its most notable exit was Wells Fargo, an estimated $22.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Signature Bank worth $37.3M.
- Handelsbanken Fonder's largest Q4 2016 buy was Signature Bank: 248,000 shares worth $37.3M.
- Handelsbanken Fonder added most to UnitedHealth in Q4 2016, an estimated $50.3M increase.
- Handelsbanken Fonder's biggest Q4 2016 reduction was Ecolab, cutting an estimated $24.6M.
- Handelsbanken Fonder fully exited Wells Fargo in Q4 2016, selling an estimated $22.1M.
- Handelsbanken Fonder's ten largest holdings make up 25% of its $3.27B portfolio in Q4 2016.
- Handelsbanken Fonder opened 14 new positions and closed 21 in Q4 2016.
- Handelsbanken Fonder's portfolio value fell 4.2% quarter-over-quarter to $3.27B.
Based on Handelsbanken Fonder's 13F filing for Q4 2016, filed 8 Feb 2017.